Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (47)

« Back to Publications

Agreement and utility between registry and trial mortality data - a data utility comparison in the BOSS trial.

Zimmermann A. et al, (2026), Trials

Barrett's Oesophagus Surveillance Versus Endoscopy at Need Study (BOSS): A Randomized Controlled Trial.

Old O. et al, (2025), Gastroenterology, 169, 1233 - 1243.e8

Lessons learned from the BOSS trial.

Old O. et al, (2025), Lancet Gastroenterol Hepatol, 10, 971 - 972

Cost-Effectiveness of Regular Surveillance Versus Endoscopy at Need for Patients With Barrett's Esophagus: Economic Evaluation Alongside the Barrett's Oesophagus Surveillance Study (BOSS) Randomized Controlled Trial.

Deidda M. et al, (2025), Gastroenterology, 169, 1244 - 1252.e7

A review of the statistical analysis of randomised controlled trials conducted within OCTRU.

Ooms A. et al, (2025), Trials, 26

Su1221: COST-EFFECTIVENESS OF REGULAR SURVEILLANCE VERSUS ENDOSCOPY AT NEED FOR PATIENTS WITH BARRETT’S ESOPHAGUS: ECONOMIC EVALUATION ALONGSIDE THE BOSS RANDOMIZED CONTROLLED TRIAL

Old O. et al, (2025), Gastroenterology, 169

622: BARRETT’S OESOPHAGUS SURVEILLANCE VERSUS ENDOSCOPY AT NEED STUDY (BOSS): A RANDOMIZED CONTROLLED TRIAL

Old O. et al, (2025), Gastroenterology, 169, S - 149

Barrett's Oesophagus Surveillance Versus Endoscopy at Need Study (BOSS): A Randomized Controlled Trial

Old O. et al, (2025), GASTROENTEROLOGY, 169

Clinical outcomes from EMERALD trial: A phase I evaluating ultra-hypofractionated MR-Guided Adaptive SABR (SMART) for localized pancreatic cancer

Mukherjee S. et al, (2025), RADIOTHERAPY AND ONCOLOGY, 206, S1783 - S1785

COST-EFFECTIVENESS OF REGULAR SURVEILLANCE VERSUS ENDOSCOPY AT NEED FOR PATIENTS WITH BARRETT'S ESOPHAGUS: ECONOMIC EVALUATION ALONGSIDE THE BOSS RANDOMIZED CONTROLLED TRIAL

Old O. et al, (2025), GASTROENTEROLOGY, 169, S709 - S710

Five-year outcomes for patients sustaining severe fractures of the lower limb from the Wound Healing in Surgery for Trauma (WHIST) trial.

Costa ML. et al, (2024), Bone Joint J, 106-B, 858 - 864

The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial

Watson M. et al, (2024), Therapeutic Advances in Musculoskeletal Disease, 16

Anti-TNF (adalimumab) injection for the treatment of pain-predominant early-stage frozen shoulder: the Anti-Freaze-Feasibility randomised controlled trial.

Hopewell S. et al, (2024), BMJ Open, 14

The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial.

Watson M. et al, (2024), Ther Adv Musculoskelet Dis, 16

Real-World Treat-to-Target Strategy in Psoriatic Arthritis: Baseline Characteristics from the MONITOR-PsA Cohort

James L. et al, (2024), ARTHRITIS & RHEUMATOLOGY, 76, 2953 - 2956

Load More